Hillsborough, CA, United States of America

Geoffrey Duyk


Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Geoffrey Duyk

Introduction

Geoffrey Duyk is a prominent inventor based in Hillsborough, California, known for his significant contributions to the field of cancer research. With a total of two patents to his name, Duyk has made strides in identifying anti-cancer drug targets, which could lead to more effective treatments for cancer patients.

Latest Patents

Duyk's latest patents focus on methods for identifying anti-cancer drug targets. These patents describe transformation constructs and transgenic animals that are utilized to identify anti-tumor agents and drug targets. The constructs generate transgenic animals with altered expression of oncogenes or tumor suppressor genes in target tissues that are not essential for viability and reproduction. This alteration can lead to abnormal proliferation in the target tissue while maintaining normal proliferation in other tissues. By generating progeny of these transgenic animals with various gene mutations, potential anti-tumor drug targets can be identified. The research also explores anti-tumor agents that mimic the effects of these gene mutations or are identified through direct administration of compounds to the transgenic animals.

Career Highlights

Geoffrey Duyk is currently associated with Exelixis, Inc., a company that focuses on developing innovative cancer therapies. His work at Exelixis has positioned him as a key player in the ongoing battle against cancer, contributing to the understanding of how specific gene mutations can lead to effective treatment options.

Collaborations

Duyk has collaborated with notable colleagues in his field, including Felix D. Karim and Casey Kopczynski. These collaborations have further enhanced the research and development of anti-cancer strategies.

Conclusion

Geoffrey Duyk's innovative work in identifying anti-cancer drug targets showcases his commitment to advancing cancer research. His contributions have the potential to lead to significant breakthroughs in cancer treatment, benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…